A phase I trial of intratumoral bispecific antibody [H 447] and activated monocytes in patients with recurrent or refractory glioblastoma multiforme
Phase of Trial: Phase I
Latest Information Update: 26 Oct 2011
At a glance
- Drugs H 447 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2005 New trial record.